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1036-118 19 pts with TC > 200mg and 52 smokers. All patients were divided into two groups 
depending upon HDL level, ie. group A(HDL < 40mg, N:66, 6 female, 58 male) and group 
B(HDL > 40mg, N:53, 37 male, 16 female). 
TC HDL LDL TG PA PT DS AS 
(mg/dl) (mg/dl) (mg/dl) (mg/dl) (mr+) (mm) (%) (“~) 
Early Improvement in Endothelial-Dependent Relaxation 
Is Related to Decreased Macrophage Infiltration and 
Plaque Formation in Experimental Atherosclerosis 
Dario Echeverri, Felix Mantes. Monica Porte, German Santamaria, William N. O’Connor, 
Pedro Ft. Moreno, Fundacion Cardio-lnfantil, Bogota, Colombia, University of Kentucky, 
Lexington, KY Group A 178+44 33i4 109+40 174*121 9*4 1.7*0.5 50*14 73*14 
Group B 198i34 49*9 11&27 155+109 6+3 1.3kO.4 41?13 63~15 
P 0.03 0.001 NS NS 0.007 0.001 0.004 0.003 
Therefore, it appears that lower the HDL level, PA is larger and PT is thicker, compared 
to patients with higher HDL level, resulting increased DS and AS in patients with lower 
HDL. There was no significant difference in plaque characteristics with 21 hard and 45 
soft plaques in group A, and 18 hard and 35 soft plaque I” group B. (P:NS). 
Thus, the level of HDL appears one of the important determinants which may affect the 
process of atherogenesis, resulting decreased plaque size in coronary artery, possibly 
through reverse transport mechanism. 
Background: Dysfunction of endothelial dependent relax&on (EDR) is observed early 
in atherosclerosis, while macrophage infiltration and plaque formation are later stages of 
the disease. To study functional and anatomical regression (R) pathways, we tested the 
hypothesis that EDR recovery is associated with macrophage reduction and decreased 
plaque formation in experimental atherosclerosis. 
Methods: Twenty-one New Zealand rabbits on 2% chol were randomized to R (Atorvas- 
tatin 2.5 mgikg/day; n=lO) or placebo (n=li) for 16 weeks. Subsequently, EDR was eval- 
uated in-vitro on 208 isolated aortic rings with acetyl-choline (Ach) pre-contracted by KCI 
and norepinephrine, using a force transducer (Kent-Scientific Co.) in organ chambers 
filled with 25 ml Krebs-Henseleit solution. Macrophage counting was performed on RAM 
11 immunostained sections. Plaque area and maximal lntimal thickness (MIT) were 
quantified by computerized planimetry. 
Results: Compared with placebo, EDR (%) improved (Flgure) while macrophages 
decreased (23 + 14 Vs. 57 * 15; P=O.OOOl) in the R group. Plaque area (mm’) (0.62 + 
0.4 Vs. 1.9 * 0.9; P=O.OOOl), and MIT (mm) (0.17 * 0.07 Vs. 0.4 * 0.16; P=O.OOOl) also 
decreased in the R group. 
Conclusion: EDR recovery is associated with macrophage reduction and decreased 
plaque formation in experimental atherosclerosis. These functional and anatomical 
effects occur simultaneously during disease R and may contribute to the reduction in clin- 
ical events observed with lipid-lowering therapy. 
1036-119 The Relationship Between High-Density Lipoprotein 
Cholesterol and Vasomotor Function 
Jeffrev T. Kuvin, Ayan R. Patel, Mandeep Sidhu, William M. Rand, Kathleen A. Sliney, 
Natesa G. Pandian, Richard H. Karas, Tufts-New England MedIcal Center, Boston, MA 
Background: Low levels of high-density lipoprotein cholesterol (HDL-C) are one of the 
most common lipid abnormalities in patients with coronary artery disease (CAD). Endot- 
helial dysfunction is also highly prevalent in patients with atherosclerosis. We sought to 
determine whether HDL-C levels correlate with endothellum-dependent vasomotion in 
patients being evaluated for CAD. 
Methods: Peripheral vascular endothelial function was assessed by high-resolution bra- 
chial artery ultrasound. Flow medlated dilation (FMD) during reactive hyperemia was 
defined as the per cent change in arterial diameter following a five minute upper am 
arterial occlusion. All patients undewent stress testing with nuclear SPECT imaging to 
determine per cent left ventricular ejection fraction (LVEF) and define the presence or 
absence of CAD. Fasting lipid profiles were measured by standard clinical laboratory 
techniques. 
Results: 151 subjects (87 men, 64 women) were enrolled with an average age of 5&l 1 
years (mean&D). 43% had hypertension, 25% had diabetes, and the average LVEF 
was 59+10% Total cholesterol, HDL-C. LDL-C. and triglyceride levels were 18&46, 
47+13, lo&37 and 154*68mg/dl, respectively. The mean FMD for the entire group was 
9.9&Z%. Subjects with an HDL-C less than 40mgidl (n=39) had lower FMD (7.4+3.6%) 
compared to those with an HDL-C greater or equal to 40mgldl (11.0*5.5%, pcO.001). 
There was a significant correlation between FMD and HDL-C level (lmear regression, 
p<O.OOl), and in multivariate analysis, HDL-C was an independent predictor of FMD. As 
expected. subjects with CAD (n=66) had lower HDL-C (40+9mgidl) and FMD (7.4*4.2%), 
while subjects without CAD (n&5) had higher HDL-C (53+13 mgidl) and FMD 
(11.7+5.2%; pcO.001). 
Conclusions: Peripheral endothelial function is abnormal in subjects with low HDL-C and 
well-preserved in those with high HDL-C These data suggest that impaired endothelial 
function associated with low HDL-C may be an additional, previously unrecognized 
mechanism contributing to the increased risk of CAD in these patients. Further studies on 
the effects of HDL-raising therapies on endothelial function appear warranted. 
1036-l 52 Morphological Characteristics of Coronary Plaque in 
Patients With Low Level of High-Density Lipoprotein 
Bvuna-il W. Choi, So-Yeon Choi, Hyuk-Jae Chang, Tae-Young Choi, Myeong-Ho Yoon, 
Gyo-Seung Hwang, Joon-Han Shin, Han-Soo Kim, Seung-Jea Tahk. Ajou University 
School of Medicine, Suwon, South Korea 
An inverse correlation between the level of high density Ilpoproteln(HDL) and the risk of 
developing coronary artery dwease(CAD) has been demonstrated in many previous epi- 
demiological studies. To characterize plaque morphology in relation to HDL level, coro- 
nary angiography and Intravascular ultrasound(lVUS) studies for measurements of 
plaque area( maximal plaque thickness(PT), diameter stenosis(DS) and area steno- 
sis(AS) were performed for 119 consecutive patients(age: 55+10, 24 female and 95 
male) with total cholesterol(TC) 186-t41 mg/dl, HDL 4OilO mg/dl, LDL 112*35 mgidl. 
and triglyceride(TG) 167+116 mg/dl. during cardiac catheterization for evaluation of sta- 
ble angina. There were 28 patients(pts) with hypertension. 11 pts with diabetes mellitus, 
1036-l 53 Prognostic Value of Simultaneous Assessment of Lipid 
and Inflammatory Markers in Patients With Stable 
Coronary Heart Disease 
Albrecht Hoffmeister, Dietrich Rothenbacher, Markus Kunze, Hermann Brenner, 
Wolfgang Koenig, University of Ulm, Ulm, Germany, German Centre for Research on 
Ageing, Heidelberg, Germany 
Background: To investigate simultaneously the role of interleukin-6 (IL-6) or C-reactive 
protein (CRP) and lipid markers in patients with stable coronary heart disease (CHD). 
Methods: Between 1996 end 1997 we recruited 312 patients aged 40-68 years with 
angiographically proven, clinically stable CHD. After median follow-up of 38.2 months 
(maximum 53.8 months) of 300 patients (96.2 %), in 60 (20%) a fatal or nonfatal cardio- 
vascular event (CVE) had occurred. 
Results: Baseline levels of interleukln-6 (IL-6) were higher (3.27 versus 2.62 pg/ml, 
pcO.02) I” patients wth a future CVE compared to those without. Levels of CRP and lipld 
markers did not statlstically significantly differ between both groups. The highest propor- 
tion of CVE was found in patients with simultaneously elevated concentrations (>median) 
of IL-6 and of total cholesterol (27.4 % vs. 15.2 %), LDL cholesterol (25.7 % vs. 13.6 %), 
or of decreased levels (<median) of HDL cholesterol (30.6 % vs. 22.2 %) compared to 
those with both markers below the median (HDL cholesterol above the median, respec- 
tively) 
After multivariate adjustment for age, gender, traditional risk factors, medication, and 
clinical features, patients with elevated levels I>medlan) of IL-6 and LDL cholesterol or of 
total cholesterol showed the highest cardiovascular nsk (hazard ratio = 2.1 (0.9-5.0). and 
2.0 (0.9.2.7), respectively) compared to patients wth lower levels (<median) of each 
biomarker. An adversely altered lipid profile alone without simultaneous elevatton of IL-6 
or CRP was only a poor predtctor for CVE. 
Conclusions: The simultaneous assessment of markers of inflammation and lipid metab- 
olism may improve cardiovascular risk assessment in patients with stable CHD, and 
might have important clinical implications (e.g. targeting of statin therapy). 
1036-l 54 Elevated C-Reactive Protein Levels and Increased High- 
Density Lipoprotein Size in a Post-Infarction Population 
Is Associated With Higher Risk for Future 
Cardiovascular Events 
David A. LQ Wojciech Zareba, Arthur J. Moss, David L. Rainwater, Charles E. Sparks, 
THROMBO Investigators, Unwersity of Rochester Medical Center, Rochester, NY 
Background: Elevated levels of C-reactive protein (CRP) have been associated with an 
increased risk of card;ovascular events, but its relationship with lipids is a sublect of con- 
tinuing investigation. We hypothesized that the combination of CRP and high-density 
lipoprotein (HDL) we is associated with an increased risk of cardiovascular events. 
Methods: The Thrombogenic Factors and Recurrent Coronary Events (THROMBO) 
study involved a total of 1045 stable post-infarction patients. Of the 947 patients who had 
available CRP and HDL size measurements, we identified a high-risk group (HRG) of 73 
patients (7.7%) who were in both the upper quartile of CRP levels and upper quartile of 
HDL particle size. The clinical characteristics and levels of selected thrombogenic and 
lipid variables for this HRG were compared to those of patbents not included in this high- 
nsk group (non-HRG). The rates of primary endpoint (death or nonfatal myocardial inf- 
arction), secondary endpoint (death, nonfatal myocardial Infarction or unstable angina) 
and death alone in these two groups were also compared. Results: The results of this 
study are shown I” the table. Conclusion: The combination of both elevated CRP levels 
and larger HDL particle size identifies a high-nsk subset of post-infarction patients. 
These patients have higher levels of thrombogenic factors and poorer clinical outcomes. 
Females account for a significant percentage of post-infarctlon patients with both ele- 
vated CRP levels and larger HDL particle size. 
Charactenstics of H&Risk Group (HRG) and Non-HRG Pus&InfarctIon Patxnts 
Characteristic Non-HRG (n=874) HRG (n=73) p-value 
Female 197 (22.5%) 38 (52.1%) <O.OOl 
D-dimer (ng/mL) 539 * 540 1260 f 2001 <O.OOl 
Von Willebrand Factor (UWL) 145.4 f 64.4 183.0 * 88.1 <O.OOl 
Fibrinogen (mg/dL) 346.5 + 84.6 423.1 f 93 6 <o 001 
Primary Endpoint 58 (6.6%) 10 (13.7%) 0.025 
Secondary Endpoint 148 (16.9%) 26 (35.6%) <o 001 
Death (all-cause) 34 (3.9%) 8 (11 .O%) 0.005 
